5-Hydroxylysine is a post-translationally modified amino acid derived from lysine, first identified in 1921. It is primarily recognized as a pharmaceutical intermediate used in the manufacturing of specialized compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 5-hydroxylysine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-(2-{Bis[(²H₃)methyl]amino}-2-oxoethyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine-6-carboxylic acid
pharmaceutical intermediate
Glimepiride sulfonamide
pharmaceutical intermediate
(S)-1-N-Boc-2-(aminomethyl)pyrrolidine
pharmaceutical intermediate
(S)-2-(Aminomethyl)-1-Cbz-pyrrolidine
pharmaceutical intermediate
Threo-5-hydroxy-L-lysine
pharmaceutical intermediate
The international HS code for 5-hydroxylysine (CAS 1190-94-9) is 2922.50.
2922.50
2922 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,5R)-2,6-diamino-5-hydroxyhexanoic acid
YSMODUONRAFBET-UHNVWZDZSA-N
C(C[C@@H](C(=O)O)N)[C@H](CN)O
Sourcing 5-hydroxylysine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.